Treatment with new antidepressants during pregnancy and lactation;Nya antidepressiva läkemedel under graviditet och amning: Läkemedelskoncentration bör följas och lägsta möjliga dos ges

Lakartidningen

Volumn 101, Issue 13, 2004, Pages 1176-1181

  Spigset, Olav ^a   Hägg, Staffan ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; REBOXETINE; SERTRALINE; VENLAFAXINE;

HUMAN; LACTATION; MALNUTRITION; PREGNANCY; PUERPERAL DEPRESSION; REVIEW;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; DRUG MONITORING; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 1842828837     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Addis A, Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 2000;30:89-94.
2. Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA 1999;282:1264-9.
3. Hendrick V, Smith LM, Suri R, Hwang S, Haynes D, Altshuler L. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 2003;188:812-5.
4. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159:2055-61.
5. McElhatton PR, Garbis HM, Eléfant E, Vial T, Bellemin B, Mestroiacovo P, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. Reprod Toxicol 1996;10:285-94.
6. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.
7. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors. JAMA 1998; 279:609-10.
8. Ericson A, Källen B, Wiholm BE. Delivery outcome after use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999;55: 503-8.
9. Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001;158:1728-30.
10. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995;15:417-20.
11. Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90:288-91.
12. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JGW, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.
13. Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32.
14. Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J Psychiatry Neurosci 2001;26:44-8.
15. Heikkinen T, Ekblad U, Palo P, Laine K. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003;73:330-7.
16. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72:184-91.
17. Spigset O, Hägg S. Excretion of psychotropic drugs into breast milk. CNS Drugs 1998;9:111-34.
18. Dodd S, Buist A, Norman TR. Antidepressants and breast-feeding. Paediatr Drugs 2000;2:183-92.
19. Nordeng H, Bergsholm YK, Bøhler E, Spigset O. Overgang av selektive serotoninreopptakshemmere til morsmelk. Tidsskr Nor Laegeforen 2001;121:199-203.
20. Hostetter A, Stowe ZN, Strader JR, McLaughlin E, Llewellyn A. Dose of selective serotonin reuptake inhibitors across pregnancy: clinical implications. Depress Anxiety 2000;11:51-7.